-+ 0.00%
-+ 0.00%
-+ 0.00%

Nicox Partner Files China Drug Application for NCX 470 Eye Drop

MT Newswires·08/10/2026 02:23:34
Listen to the news
02:23 AM EDT, 08/10/2026 (MT Newswires) -- Nicox's (ALCOX.PA) exclusive licensee in China, Ocumension Therapeutics, lodged a new drug application for eye drop NCX 470 as a treatment to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The application to the Center for Drug Evaluation of China's National Medical Products Administration includes data from the phase 3 Mont Blanc and Denali trials, with the latter including Chinese clinical sites, the Paris-listed ophthalmology company said Monday.